UCB - Pre Tax Profit

Stock Price
234.90
Daily Change
5.00 2.17%
Monthly
-9.31%
Yearly
45.81%
Q2 Forecast
231.88

UCB reported EUR789M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Alcon AG USD 240M 24M Mar/2026
Almirall EUR 30.32M 22M Dec/2025
Amarin USD -852K 7.26M Dec/2025
argenx SE USD 403.29M 17.24M Dec/2025
AstraZeneca USD 3.91B 1.28B Mar/2026
Bayer EUR -3.37B 2.21B Dec/2025
Genmab DKK 55M 427M Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Lakefront Biotherapeutics EUR 13.96M 769.2M Mar/2026
Lonza CHF 624M 197M Dec/2024
Merck EUR 401M 886.1M Dec/2025
Novartis USD 3.84B 802M Mar/2026
Orion EUR 113.4M 213.6M Mar/2026
Recordati EUR 151.97M 7.02M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
UCB EUR 789M 427M Jun/2025